DTILPrecision BioSciences, Inc.

DTIL Stock Price, Valuation & Chart | Precision BioSciences, Inc.

Compare

$7.450-0.19 (-2.49%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology DTIL intrinsic value DTIL calculated fair value vs price

Overview Financials Dividends Ratios

DTIL Historical price chart

DTIL Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization95.57M

PE Ratio-2.53

EPS-2.94

Trading Volume358.87K

Today's High/Low7.82/7.24

Dividend Yield0.00

52 Week High/Low9.62/3.53

Shares Outstanding12.83M

DTIL Financial Statement

DTIL Analyst ratings

DTIL Analysis & performance metrics

DTIL Company profile

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers…

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific type of immune cell is genetically…

DTIL Management team

Name

Position

Murray Abramson M.D., M.P.H.

Senior Vice President & Head of Clinical Development

Cassie Gorsuch Ph.D.

Chief Scientific Officer

Juli Blanche

Chief People Officer

Cindy Atwell

Chief Development & Business Officer

Jefferson J. Smith Ph.D.

Co-Founder & Chief Research Officer

Naresh TannaCEO

Chief of Staff to Chief Executive Officer & Head of Investor Relations

Michael AmorosoCEO

President, Chief Executive Officer & Director

John Alexander Kelly R.Ph.CFO

Chief Financial Officer & Principal Accounting Officer

Name

Position

Murray Abramson M.D., M.P.H.

Senior Vice President & Head of Clinical Development

Cassie Gorsuch Ph.D.

Chief Scientific Officer

Juli Blanche

Chief People Officer

Cindy Atwell

Chief Development & Business Officer

Jefferson J. Smith Ph.D.

Co-Founder & Chief Research Officer

Naresh TannaCEO

Chief of Staff to Chief Executive Officer & Head of Investor Relations

Michael AmorosoCEO

President, Chief Executive Officer & Director

John Alexander Kelly R.Ph.CFO

Chief Financial Officer & Principal Accounting Officer

Management Team

Murray Abramson M.D., M.P.H.

Senior Vice President & Head of Clinical Development

Cassie Gorsuch Ph.D.

Chief Scientific Officer

Juli Blanche

Chief People Officer

Cindy Atwell

Chief Development & Business Officer

Jefferson J. Smith Ph.D.

Co-Founder & Chief Research Officer

Naresh TannaCEO

Chief of Staff to Chief Executive Officer & Head of Investor Relations

Michael AmorosoCEO

President, Chief Executive Officer & Director

John Alexander Kelly R.Ph.CFO

Chief Financial Officer & Principal Accounting Officer

Management

Murray Abramson M.D., M.P.H.

Senior Vice President & Head of Clinical Development

Cassie Gorsuch Ph.D.

Chief Scientific Officer

Juli Blanche

Chief People Officer

Cindy Atwell

Chief Development & Business Officer

Jefferson J. Smith Ph.D.

Co-Founder & Chief Research Officer

Naresh TannaCEO

Chief of Staff to Chief Executive Officer & Head of Investor Relations

Michael AmorosoCEO

President, Chief Executive Officer & Director

John Alexander Kelly R.Ph.CFO

Chief Financial Officer & Principal Accounting Officer

Total 8 executives

DTIL Frequently asked questions

What is Precision BioSciences, Inc. (DTIL) Stock Price?

Current stock price of Precision BioSciences, Inc. (DTIL) stock is $7.450. The stock price is -2.49% lower in the session. The intraday range can be seen from this page. Volume of Precision BioSciences, Inc. (DTIL) stock is 358.87K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Precision BioSciences, Inc. (DTIL) stock price going up or down today?

The stock price of Precision BioSciences, Inc. (DTIL) can change with earnings, company news, and overall market sentiment. Precision BioSciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Precision BioSciences, Inc. stock expensive at its current price?

Whether Precision BioSciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for DTIL on this page is -2.53. EPS on this page is -2.94. Compare those figures with peers and growth expectations before deciding if the current Precision BioSciences, Inc. price is justified.

How has the stock price of Precision BioSciences, Inc. (DTIL) performed historically?

Historical performance for Precision BioSciences, Inc. (DTIL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how DTIL reacted to past earnings and market events.

Should I buy Precision BioSciences, Inc. (DTIL) stock, at this price?

Buying Precision BioSciences, Inc. (DTIL) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.